MediWound (MDWD) Tops Q2 EPS by 7c

MediWound (NASDAQ: MDWD) reported Q2 EPS of ($0.19), $0.07 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $165 thousand versus the consensus estimate of $220 thousand.

For earnings history and earnings-related data on MediWound (MDWD) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Studio City International Holdings Limited (MSC) Reports Q2 Loss of $0.02
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance